VEGFD and tuberous sclerosis: Our data are in line with previous observations that in vitro effects of sirolimus differ among distinct cell lineages51 and TSC patients display high levels of the pro-angiogenic molecules VEGF-A and VEGF-D (vascular epithelial growth factors A and D)52.